Guiyedi K, Parquet M, Aoufouchi S, Chauzeix J, Rizzo D, Al Jamal I
Cancers (Basel). 2024; 16(22).
PMID: 39594704
PMC: 11592262.
DOI: 10.3390/cancers16223749.
Guo L, Xia Y, Li H, Wang Z, Xu H, Dai X
Cancer Gene Ther. 2023; 30(8):1124-1133.
PMID: 37225855
DOI: 10.1038/s41417-023-00624-z.
Tao Z, Wu X
Methods Mol Biol. 2022; 2594:107-131.
PMID: 36264492
PMC: 9724592.
DOI: 10.1007/978-1-0716-2815-7_9.
Bhardwaj V, He J, Jain A
Med Oncol. 2022; 39(12):227.
PMID: 36175776
DOI: 10.1007/s12032-022-01834-5.
Song K, Minami J, Huang A, Dehkordi S, Lomeli S, Luebeck J
Cancer Discov. 2021; 12(4):1046-1069.
PMID: 34930786
PMC: 9192483.
DOI: 10.1158/2159-8290.CD-20-0936.
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets.
Park J, Pyun W, Park H
Cells. 2020; 9(10).
PMID: 33081387
PMC: 7602974.
DOI: 10.3390/cells9102308.
The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.
Ragusa D, Makarov E, Britten O, Moralli D, Green C, Tosi S
Cancer Rep (Hoboken). 2020; 2(5):e1207.
PMID: 32721124
PMC: 7941496.
DOI: 10.1002/cnr2.1207.
Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat.
Dong Y, Tu R, Liu H, Qing G
Signal Transduct Target Ther. 2020; 5(1):124.
PMID: 32651356
PMC: 7351732.
DOI: 10.1038/s41392-020-00235-2.
Mechanisms Underlying Recurrent Genomic Amplification in Human Cancers.
Tanaka H, Watanabe T
Trends Cancer. 2020; 6(6):462-477.
PMID: 32383436
PMC: 7285850.
DOI: 10.1016/j.trecan.2020.02.019.
Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma.
Southgate H, Chen L, Curtin N, Tweddle D
Front Oncol. 2020; 10:371.
PMID: 32309213
PMC: 7145987.
DOI: 10.3389/fonc.2020.00371.
The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells.
Anderson 3rd D, Murphy T, Eisenman R, Murphy K
Proc Natl Acad Sci U S A. 2020; 117(9):4885-4893.
PMID: 32071205
PMC: 7060746.
DOI: 10.1073/pnas.1915060117.
Role of genomic instability in human carcinogenesis.
Moon J, Lu A, Moon C
Exp Biol Med (Maywood). 2019; 244(3):227-240.
PMID: 30760030
PMC: 6425100.
DOI: 10.1177/1535370219826031.
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.
Mack E, Marquardt A, Langer D, Ross P, Ultsch A, Kiehl M
Haematologica. 2018; 104(2):277-287.
PMID: 30190345
PMC: 6355503.
DOI: 10.3324/haematol.2018.194258.
The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues.
Goetzman E, Prochownik E
Front Endocrinol (Lausanne). 2018; 9:129.
PMID: 29706933
PMC: 5907532.
DOI: 10.3389/fendo.2018.00129.
Systematic target function annotation of human transcription factors.
Li Y, Altman R
BMC Biol. 2018; 16(1):4.
PMID: 29325558
PMC: 5795274.
DOI: 10.1186/s12915-017-0469-0.
MYC Deregulation in Primary Human Cancers.
Kalkat M, De Melo J, Hickman K, Lourenco C, Redel C, Resetca D
Genes (Basel). 2017; 8(6).
PMID: 28587062
PMC: 5485515.
DOI: 10.3390/genes8060151.
The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects.
Nguyen L, Papenhausen P, Shao H
Genes (Basel). 2017; 8(4).
PMID: 28379189
PMC: 5406863.
DOI: 10.3390/genes8040116.
FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.
Li X, Wang W, Xi Y, Gao M, Tran M, Aziz K
Cell Rep. 2016; 16(2):487-497.
PMID: 27346356
PMC: 4946253.
DOI: 10.1016/j.celrep.2016.06.004.
Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive.
Mishra S, Whetstine J
Mol Cell Biol. 2016; 36(7):1050-63.
PMID: 26755558
PMC: 4800790.
DOI: 10.1128/MCB.00652-15.
c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
Gonzalez-Prieto R, Cuijpers S, Kumar R, Hendriks I, Vertegaal A
Cell Cycle. 2015; 14(12):1859-72.
PMID: 25895136
PMC: 4613540.
DOI: 10.1080/15384101.2015.1040965.
